Priyam Shah | executive |
Brian McKelligon | executive |
John Ek | executive |
Yih-Ming Tu | analyst |
John Sourbeer | analyst |
Kyle Mikson | analyst |
Timothy Chiang | analyst |
Mason Carrico | analyst |
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Akoya Biosciences Incorporated Third Quarter 2023 Earnings Conference Call. [Operator Instructions]At this time, I would like to turn the conference over to Mr. Priyam Shah. Mr.